vTv Therapeutics, Inc. Class A Forecast, price target & analysts
vTv Therapeutics, Inc. Class A Target price 2025 - Analyst rating & recommendation
vTv Therapeutics, Inc. Class A Classifications & Recommendation:
vTv Therapeutics, Inc. Class A Price Target
| Target Price | $35.00 |
| Price | $19.66 |
| Potential |
78.03%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a vTv Therapeutics, Inc. Class A price target 2026.
The average vTv Therapeutics, Inc. Class A target price is $35.00.
This is
78.03%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend vTv Therapeutics, Inc. Class A to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the vTv Therapeutics, Inc. Class A stock has an average upside potential 2026 of
78.03%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 1.00 |
| 100.00% |
1 Analyst has issued a sales forecast vTv Therapeutics, Inc. Class A 2024 . The average vTv Therapeutics, Inc. Class A sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2023 | $0.0 | 100.00% |
|---|---|---|
| 2025 |
$0.0
100.00%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | 9.62 |
Based on analysts' sales estimates for 2024, the vTv Therapeutics, Inc. Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 9.62 | 99.53% |
|---|---|---|
| 2024 |
9.62
0.00%
Unlock
|
|
P/S ratio
| Current | 48.07 | 97.18% |
|---|---|---|
| 2024 |
48.07
0.00%
Unlock
|
|
vTv Therapeutics, Inc. Class A...
Current vTv Therapeutics, Inc. Class A Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Alliance Global Partners | Locked ➜ Locked | Locked | Dec 09 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Alliance Global Partners: Locked ➜ Locked
|
Dec 09 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
